- Home
- XTNT vs IVVD Comparison
XTNT vs IVVD Comparison
Compare XTNT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- IVVD
- Stock Information
- Founded
- XTNT N/A
- IVVD 2020
- Country
- XTNT United States
- IVVD United States
- Employees
- XTNT N/A
- IVVD N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- IVVD Health Care
- Exchange
- XTNT Nasdaq
- IVVD Nasdaq
- Market Cap
- XTNT 60.9M
- IVVD 69.0M
- IPO Year
- XTNT N/A
- IVVD 2021
- Fundamental
- Price
- XTNT $0.74
- IVVD $0.72
- Analyst Decision
- XTNT
- IVVD Strong Buy
- Analyst Count
- XTNT 0
- IVVD 3
- Target Price
- XTNT N/A
- IVVD $5.85
- AVG Volume (30 Days)
- XTNT 74.4K
- IVVD 1.7M
- Earning Date
- XTNT 08-07-2025
- IVVD 08-13-2025
- Dividend Yield
- XTNT N/A
- IVVD N/A
- EPS Growth
- XTNT N/A
- IVVD N/A
- EPS
- XTNT N/A
- IVVD N/A
- Revenue
- XTNT $122,298,000.00
- IVVD $36,688,000.00
- Revenue This Year
- XTNT $11.64
- IVVD $446.60
- Revenue Next Year
- XTNT $7.59
- IVVD $112.63
- P/E Ratio
- XTNT N/A
- IVVD N/A
- Revenue Growth
- XTNT 20.81
- IVVD N/A
- 52 Week Low
- XTNT $0.33
- IVVD $0.35
- 52 Week High
- XTNT $0.83
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- XTNT 48.39
- IVVD 43.88
- Support Level
- XTNT $0.57
- IVVD $0.68
- Resistance Level
- XTNT $0.65
- IVVD $0.82
- Average True Range (ATR)
- XTNT 0.05
- IVVD 0.06
- MACD
- XTNT -0.01
- IVVD -0.02
- Stochastic Oscillator
- XTNT 33.33
- IVVD 11.07
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.